Wells Fargo & Company GYRE THERAPEUTICS INC Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024
Number of Shares
3,103
Previous 2,987 3.88%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
N/A
116 Added 3.88%
3,103 $0
Q2 2024

Aug 13, 2024
BUY
N/A
2,891 Added 3011.46%
2,987 $0
Q1 2024

May 10, 2024
BUY
N/A
2 Added 2.13%
96 $0
Q4 2023

Feb 09, 2024
BUY
N/A
94 New
94 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email